Cited by 124Neuroendocrine regulation and behaviorAutism Spectrum Disorder ResearchGenetics and Neurodevelopmental Disorders

Autism and Oxytocin: New Developments in Translational Approaches to Therapeutics

Open access
Green, Joshua J., Hollander, Eric·2010·Neurotherapeutics

Abstract

Autism is a neurodevelopmental disorder characterized by dysfunction in three core symptom domains: speech and communication deficits, repetitive or compulsive behaviors with restricted interests, and social impairment. The neuropeptide oxytocin, along with the structurally similar peptide arginine vasopressin, may play a role in the etiology of autism, and especially in the social impairment domain. Oxytocin is a nonapeptide (i.e., it has nine amino acids). It is synthesized in magnocellular neurons in the paraventricular nucleus and the supraoptic nucleus of the hypothalamus and is released into the bloodstream by way of axon terminals in the posterior pituitary. Oxytocin is released both peripherally, where it is involved in milk letdown and the facilitation of uterine contractions, and centrally, where it acts as a neuromodulator along with arginine vasopressin. Here, we discuss relevant translational research pertaining to the role of oxytocin in social and repetitive behaviors and consider clinical implications. We also discuss current research limitations, review recent preliminary findings from studies involving oxytocin in autism spectrum disorder patient populations, and point to possible directions for future research.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nurt.2010.05.006

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In subjects diagnosed with autism, a single intranasal administration of OXT might improve, at least temporarily, emotion recognition abilities in the Reading the Mind in the Eyes test and the patients' ability to process socially relevant cues in a computer-based game.

    “Moreover, in subjects diagnosed with autism, a single intranasal administration of OXT might be able to improve, at least temporarily, emotion recognition abilities in the Reading the Mind in the Eyes test and the patients' ability to process socially relevant cues in a computer-based game (Andari et al, 2010;Green and Hollander, 2010;Guastella et al, 2010).”

    From Chronic and acute intranasal oxytocin produce divergent social effects in mice (2014) · cites this paper as Green and Hollander, 2010

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Hollander E, Bartz J, Chaplin W, et al. Oxytocin increases reten- tion in social cognition in autism. Biol Psychiatry 2007;61:498 - 450.
  2. Ann N Y Acad Sci 1992;652:243-252.
  3. Bartz J, Young L. Oxytocin, social cognition, and autism. 2010 (in press).

Cited by

Sorted by citations

Authors
Green, J. J., & Hollander, E.
Affiliations
Albert Einstein College of Medicine (US)
Corresponding author
Hollander, Eric
Venue
Neurotherapeutics
Publisher
Elsevier BV
Published
2010-07
Volume
7
Issue
3
Pages
250-257
ISSN
1878-7479 (ISSN-L)
OpenAlex
W2030809876
Cited by
124
References
86
Citations by year
2026: 1 · 2025: 1 · 2024: 5 · 2023: 7 · 2022: 8 · 2021: 3 · 2020: 4 · 2019: 4 · 2018: 8 · 2017: 5 · 2016: 9 · 2015: 10 · 2014: 16 · 2013: 11 · 2012: 16
FWCI
1.73
Type
journal article
Language
en
Open access
Locations
  • Neurotherapeutics (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Alliance for Research on Schizophrenia and Depression
  • National Institutes of Health
  • National Institute of Mental Health
Topics
  • Social Sciences › Psychology › Social Psychology › Neuroendocrine regulation and behavior
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
autism spectrum disorder, oxytocin, vasopressin, social dysfunction, repetitive behavior, social behavior, hypothalamic neuropeptides, paraventricular nucleus, supraoptic nucleus, milk let-down, uterine contraction, neuromodulation
MeSH terms
Animals, Arginine Vasopressin, Autistic Disorder, Humans, Oxytocin, Social Behavior

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review